Trigeminal Neuralgia Market Trends and Growth Analysis, Emerging Drugs, Leading Companies, and Epidemiology Forecast

Trigeminal Neuralgia Market Trends and Growth Analysis, Emerging Drugs, Leading Companies, and Epidemiology Forecast

“Delveinsight Business Research LLP”
DelveInsight’s “Trigeminal Neuralgia Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Trigeminal Neuralgia, historical and forecasted epidemiology as well as the Trigeminal Neuralgia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Trigeminal Neuralgia (TN), also known as tic douloureux, is a chronic pain condition that affects the trigeminal or fifth cranial nerve, one of the most widely distributed nerves in the head. TN is a form of neuropathic pain (pain associated with nerve injury or nerve lesion). Trigeminal neuralgia is categorized in two types: primary (idiopathic) or secondary.

TN occurs most often in people over age 50, although it can occur at any age, including infancy. The possibility of TN being caused by multiple sclerosis increases when it occurs in young adults. The incidence of new cases is approximately 12 per 100,000 people per year; the disorder is more common in women than in men.

Get FREE sample copy at:

The Trigeminal Neuralgia market report also covers emerging drugs, current treatment practices, Trigeminal Neuralgia market share of the individual therapies, current and forecasted Trigeminal Neuralgia Market Size from 2017 to 2030 segmented by seven major markets. 

The report provides a detailed current Trigeminal Neuralgia treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market. 

Trigeminal Neuralgia Market

Trigeminal Neuralgia Market Key Facts

  • As per the National Organization for Rare Disorders (NORD), trigeminal neuralgia affects females slightly more often than males. Although the exact incidence is unknown, approximately 10,000–15,000 new cases occur each year in the United States.

  • A study conducted by Obermann et al. in Germany titled “Treatment options in trigeminal neuralgia,” indicated that the incidence of trigeminal neuralgia (TN) is 4.3 per 100,000 persons per year, with a slightly higher incidence for women (5.9 per 100,000) as compared to men (3.4 per 100,000). There is a lack of certainty regarding the etiology and pathophysiology of TN.

  • A study conducted by Manzoni et al. (2005) in Italy titled “Epidemiology of typical and atypical craniofacial neuralgias” stated that trigeminal neuralgia (TN) has an incidence ranging from about 4–5 per 100,000 per year up to 20 per 100,000 per year after age 60. The female‐to‐male ratio is about 3:2.

Key Benefits of Trigeminal Neuralgia Market Report

  • Trigeminal Neuralgia market report provides an in-depth analysis of Trigeminal Neuralgia Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major markets, i.e. EU5 (Germany, Italy, Spain, France, and the UK), Japan, and the United States.

  • The Trigeminal Neuralgia market report will help in developing business strategies by understanding the Trigeminal Neuralgia Market trends & developments, key players, and future market competition that will shape and drive the Trigeminal Neuralgia market in the upcoming years.

  • The Trigeminal Neuralgia market report covers Trigeminal Neuralgia current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.

  • The report provides a detailed assessment of the Trigeminal Neuralgia market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population,  comparative analysis of pipeline products with detailed clinical profiles, and other factors. 

Trigeminal Neuralgia Market

Trigeminal Neuralgia market size is anticipated to increase during the study period owing to the rise in the number of incident cases in the 7MM. The expected launch of the upcoming therapies will also fuel the growth of the market.

The Trigeminal Neuralgia market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Trigeminal Neuralgia market trends by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology. 

The report gives a thorough detail of the Trigeminal Neuralgia market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders. 

Trigeminal Neuralgia Epidemiology

The Trigeminal Neuralgia epidemiology section covers insights about the historical and current Trigeminal Neuralgia patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Trigeminal Neuralgia Epidemiology Segmentation –

  • Incident Cases of Trigeminal Neuralgia (TN)

  • Gender‐Specific Cases of Trigeminal Neuralgia (TN)

  • Diagnosed and Treatable Cases of Trigeminal Neuralgia

Trigeminal Neuralgia Drugs Uptake and Key Market Players

The Trigeminal Neuralgia Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Trigeminal Neuralgia market or expected to get launched in the market during the study period. The analysis covers Trigeminal Neuralgia market uptake by drugs; patient uptake by therapies; and sales of each drug.    

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The dynamic of the Trigeminal Neuralgia (TN) market is expected to change due to the improvement in the diagnosis, incremental healthcare expenditure across the world, and expected launch of emerging therapies during the forecast period. Companies all over the globe are persistently working toward the development of new treatment therapies.

Get FREE sample copy at:

Trigeminal Neuralgia Companies:
Biohaven Pharmaceuticals
And many others.

Trigeminal Neuralgia Therapies covered in the report include:
Vixotrigine (BIIB074)
And many more.

Table of Content

1. Key Insights

2. Executive Summary 

3. Trigeminal Neuralgia Competitive Intelligence Analysis

4. Trigeminal Neuralgia Market Overview at a Glance

5. Trigeminal Neuralgia Disease Background and Overview

6. Trigeminal Neuralgia Patient Journey

7. Trigeminal Neuralgia Epidemiology and Patient Population

8. Trigeminal Neuralgia Treatment Algorithm, Current Treatment, and Medical Practices

9. Trigeminal Neuralgia Unmet Needs

10. Key Endpoints of Trigeminal Neuralgia Treatment

11. Trigeminal Neuralgia Marketed Products

12. Trigeminal Neuralgia Emerging Therapies

13. Trigeminal Neuralgia Seven Major Market Analysis

14. Attribute Analysis

15. Trigeminal Neuralgia Market Outlook (7 major markets)

16. Trigeminal Neuralgia Access and Reimbursement Overview

17. KOL Views on the Trigeminal Neuralgia Market.

18. Trigeminal Neuralgia Market Drivers

19. Trigeminal Neuralgia Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Get FREE sample copy at:

Latest Reports By DelveInsight –
Neuromodulation Devices Market Insights
DelveInsight’s ‘Neuromodulation Devices Market Insights, Competitive Landscape and Market Forecast – 2025’ report delivers an in-depth understanding of Neuromodulation Devices and the historical and forecasted Neuromodulation Devices market trends in the US, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan. 

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States